FDA grants De Novo authorisation for Distalmotion's Dexter in inguinal hernia repair

Distalmotion/Dexter

The FDA authorised Dexter for adult laparoscopic inguinal hernia repair, opening the US market to the Swiss robot. Distalmotion targets outpatient settings, where it says over 90% of US inguinal hernia repairs already happen. More than 1,300 patients had been treated with Dexter in Europe by then.

• De Novo marketing authorisation for adults aged 22 and older.
• Mobile, modular system designed for outpatient departments and ambulatory surgery centres.
• Open platform: works with third-party 3D imaging, energy devices and vessel sealers.
• Uses single-use, fully wristed instruments that need no reprocessing.